Executive Summary
The new report, Drug Safety in the Post-Vioxx Era: New legislation, regulation and company strategies in Europe and the US, examines the actions taken by legislative and regulatory bodies in response to recent drug safety concerns surrounding the COX-2 inhibitors and antidepressants. The report also analyzes the different management, marketing and technological strategies companies are pursuing to ensure the safety of their products, and provides predictions for the future of drug safety regulation in the US and EU.
Other selected research from the 'Europe' category:
Benchmarking Best Practice at Patent Expiry in Europe - Maximizing Return on Investment of Late-Stage Lifecycle Management
Successfully managing the lifecycle of molecules within marketed portfolios is an essential capability for the pharma industry. With R&D productivity stalling, and profit margins increasingly eroded by cost containment initiatives, maximizing the return on investment of in-line brands, by extending the time on the market without generic competition, is a key objective for pharmaceutical companies. Learn More
Online Continuing Medical Education: Trends in the US and European eCME Markets
The value of CME is widely recognized in both the US and Europe. Even so, the approaches these two regions have taken with regard to the regulation, provision and funding of CME activities vary considerably. Therefore, pharmaceutical companies must take into consideration regional differences that affect their role in the development and provision of both traditional and online CME activities. Learn More
Other selected research from the 'USA' category:
Pharmaceuticals - North America (NAFTA) Industry Guide
Datamonitor’s Pharmaceuticals - North America (NAFTA) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the North American Free Trade Agreement... Learn More
Commercial Perspectives: US Hip and Knee Replacement - Market surges in new millennium
The US hip and knee replacement markets have undergone a resurgence in growth in the past three years, and it has been more than just an aging population that has driven this growth. This analysis evaluates current market factors and trends, and presents the key drivers that will spark additional growth in the next five years. Learn More
Other selected research from the 'Regulation & Policy' category:
eHealth Regulations in Europe: Understanding the Changing European Legislative Landscape
The coming year will be one of immense change for the pharmaceutical industry in Europe. The continued development of the eEconomy is critical to the continued growth and success of the European pharmaceutical market. Companies that implement forward-looking strategies will be able to hasten compliance and take full advantage of the opportunities presented by future regulations. Learn More
Intellectual Property Protection and Regulatory Regimes in Emerging Markets
The report traces how regulatory policy, in particular relating to intellectual property, has shaped the emerging markets. In doing so, it explores differences in the treatment of generics and innovative... Learn More
Other selected research from the 'Autoimmune & Inflammation' category:
Commercial Insight: Asthma and COPD - Control is the Goal
The world market for asthma/COPD drugs, valued at $13.3 billion in 2003, is forecast to grow to $19.0 billion by 2009, driven by the expansion of combination steroid/bronchodilator products into a wider spectrum of patients, and strong growth in COPD specific therapies. GlaxoSmithKline and Merck remain the indisputable leaders in asthma, with Pfizer steadily building a presence in COPD. Learn More
Stakeholder Insight: Inflammatory Bowel Disease - Debate over early aggressive treatment continues
Inflammatory bowel disease (IBD) is a chronic inflammatory condition that affects the gastrointestinal tract causing a number of distressing symptoms such as bleeding, diarrhea and abdominal pain. IBD includes key subsets Crohn’s disease and ulcerative colitis, both of which can significantly impact on the quality of life of an individual. Learn More